Skip to main content
Fig. 2 | Cancer Cell International

Fig. 2

From: Post treatment NLR is a predictor of response to immune checkpoint inhibitor therapy in patients with esophageal squamous cell carcinoma

Fig. 2

Association between response to anti-PD-1 treatment and 6 weeks NLR decrease > 50%, increase > 50% and no change in ESCC patients. The patients were defined as decrease > 50%, increase > 50% and no change groups by the difference between baseline NLR and 6 weeks NLR and then analyzed with Kaplan–Meier survival curves

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us